Brian Edward Miller - 10 Nov 2025 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Signature
By: Thanh Nhan Phan For: Brian Miller
Issuer symbol
ISRG
Transactions as of
10 Nov 2025
Net transactions value
-$1,254,754
Form type
4
Filing time
12 Nov 2025, 14:03:12 UTC
Previous filing
12 Mar 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Miller Brian Edward EVP & Chief Digital Officer 1020 KIFER ROAD, SUNNYVALE By: Thanh Nhan Phan For: Brian Miller 12 Nov 2025 0002010301

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $297,748 +1,298 +23% $229.39 7,056 10 Nov 2025 Direct F1
transaction ISRG Common Stock Sale $746,350 -1,298 -18% $575.00 5,758 10 Nov 2025 Direct F1
transaction ISRG Common Stock Options Exercise $459,998 +2,202 +38% $208.90 7,960 10 Nov 2025 Direct F1
transaction ISRG Common Stock Sale $1,266,150 -2,202 -28% $575.00 5,758 10 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,202 -51% $0.000000 2,115 10 Nov 2025 Common Stock 2,202 $208.90 Direct F1, F2
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,298 -16% $0.000000 6,602 10 Nov 2025 Common Stock 1,298 $229.39 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 10, 2025.
F2 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
F3 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.